Streetbeat News

Products Services

CAH

CVS

RADCQ

TGT

WBA

The FDA has issued a warning against the use of certain over-the-counter eye drops from brands including CVS Health Corp and Cardinal Health Inc, due to concerns of potential eye infections and vision loss. The products are distributed by CVS Health, Rite Aid Corp, Cardinal Health, and Target Corp's Up & Up brand, as well as Velocity Pharma. In response, CVS, Rite Aid, and Target are removing these products from their store shelves and online platforms.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 1:34 pm

BIMI

BIMI International Medical Inc. has announced that its subsidiary, Phenix Bio Inc, has appointed a non-exclusive distributor in Mainland China. The distributor is required to make annual purchases of at least $5M to maintain its status.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:29 pm

ASTI

Ascent Solar has achieved an efficiency of 17.55% for its CIGS technology, marking a significant increase from 10.8% in early September 2023. The company has been working to optimize its manufacturing processes and chemistry, resulting in steady efficiency improvements.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:27 pm

AUVI

Applied UV Inc (AUVI) has been granted new patents by the USPTO for its Airo™ Vortex UV disinfection technology and PCO, and the Fighter Flex™ HVAC system. The company has also entered into a strategic partnership with Canon Virginia. These developments reflect Applied UV's commitment to advancing innovation in disinfection technology.

Portfolio Pulse from Henry Khederian

October 30, 2023 | 1:21 pm

TYL

Tyler Technologies has partnered with the Naperville, Illinois Police Department to provide integrated public safety solutions. The partnership aims to improve efficiency and experience for Naperville's public safety staff and enhance transparency with the community.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:21 pm

CVM

CEL-SCI Corporation (NYSE:CVM) has released a letter to shareholders detailing the efficacy of Multikine in treating head and neck cancer patients and the company's plan to seek immediate regulatory approval. The company presented new data at the European Society for Medical Oncology conference showing Multikine's superior efficacy. The company plans to seek approval for immediate patient access to Multikine without waiting on the results of a new trial wherever possible.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:21 pm

PTPI

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) is developing an AI/machine learning tool to help potential users more effectively self-select for its erectile dysfunction drug STENDRA. The technology is being developed in response to FDA feedback and is expected to be refined and completed through third-party technology partnerships. The company aims to make STENDRA the first erectile dysfunction drug to achieve OTC status in the United States.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:20 pm

AAPL

Apple Inc. is set to host its 'Scary Fast' launch event, where it is expected to unveil M3-powered iMacs and MacBook Pros. The event will be streamed online and is also expected to feature new horror games for Mac and thrillers on Apple TV+. The event will take place on October 30.

Portfolio Pulse from Rounak Jain

October 30, 2023 | 1:17 pm

GOVX

GeoVax has begun site expansion for the Phase 2 trial of its next-generation COVID-19 vaccine, which is designed to protect immunocompromised patients against severe COVID-19.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:16 pm

PHAT

Phathom Pharmaceuticals Inc (NASDAQ:PHAT) shares are trading higher after the company announced FDA approval of its reformulated vonoprazan tablets for both Voquenza Triple Pak and Voquenza Dual Pak for the treatment of Helicobacter pylori infection in adults. The company plans to host an investor call in November to discuss its U.S. commercial launch plans.

Portfolio Pulse from Adam Eckert

October 30, 2023 | 1:16 pm